Company intelligence / Profile preview

Prevail Partners

Philadelphia, Pennsylvania, United Statesprevailpartners.com ↗

Ownership: Private
Employees: ~8
Development stage: Phase 2

Overview

Prevail Partners is an active life sciences-focused investment fund that provides capital and strategic support to clinical-stage biotech and pharma companies. It does not itself conduct clinical trials or have its own drug pipeline but invests in companies developing new therapies, including those targeting cancer resistance mechanisms.

Industry: Investors

Partnerships

Kairos Pharma Ltd.

Beyond the preview

Go deeper on Prevail Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prevail Partners.

Explore the full profile